HOME >> MEDICINE >> NEWS
New study finds kelp can reduce level of hormone related to breast cancer risk

Berkeley -- A type of vegetation that can often be found washed ashore on beaches may soon emerge as a new player in the field of cancer-fighting foods. A new study led by researchers at the University of California, Berkeley, has found that a diet containing kelp seaweed lowered levels of the potent sex hormone estradiol in rats, and raised hopes that it might decrease the risk of estrogen-dependent diseases such as breast cancer in humans.

"This study opens up a new avenue for research leading to cancer preventive agents," said Martyn Smith, UC Berkeley professor of environmental health sciences and co-author of the study. "Kelp is a little studied nutrient, but there's good reason to look at it more closely."

These new results, to be published Feb. 2 in the Journal of Nutrition, shine a new light onto the Japanese diet. Prior studies have shown that Japanese women have longer menstrual cycles and lower serum estradiol levels than their Western counterparts, which researchers say may contribute to their lower rates of breast, endometrial and ovarian cancers. Scientists have been searching Asian diets for clues to the lower rates of cancer, with the lion's share of attention being given to soy.

"Brown kelp seaweed makes up more than 10 percent of the Japanese diet," said Christine Skibola, assistant research toxicologist at UC Berkeley's School of Public Health and lead author of the study. "Soy has gotten most of the attention, but our study suggests that kelp may also contribute to these reduced cancer rates among Japanese women."

The researchers say that the type of kelp used in this study, bladderwrack seaweed (Fucus vesiculosus), is closely related to wakame and kombu, the brown seaweeds that are most commonly consumed in Japan. Bladderwrack seaweed is the primary form of kelp sold in the United States. They say these study results support the need for more research on wakame and kombu.

Skibola said she began the anim
'"/>

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley
2-Feb-2005


Page: 1 2 3 4

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New study finds kelp can reduce level hormone related breast cancer risk

(Date:6/18/2013)... The new swab, designed for infants ... the tip allowing for faster collection of infant saliva. ... (SIS) can be tested for cortisol, cotinine, testosterone, ... diameter of the Salimetrics Infant Swab has been increased ... access more saliva in the newborn’s mouth and thereby ...
(Date:6/17/2013)... (PRWEB) June 18, 2013 A ground-breaking ... stroke patients a new rehabilitation treatment. , Constraint ... and offers a new intensive rehabilitation program to help ... those with cerebral palsy and some other neurological conditions. ... “rewires” the brain helping people to improve the use ...
(Date:6/17/2013)... IL (PRWEB) June 17, 2013 The ... after mild traumatic brain injury (MTBI) closely resembles that ... study published online in the journal Radiology. , ... seen in early Alzheimer’s dementia,” said the study’s lead ... the Division of Neuroradiology at the University of Pittsburgh ...
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... distribution of white matter brain abnormalities in some patients ... found in early Alzheimer,s dementia, according to a new ... , "Findings of MTBI bear a striking resemblance ... study,s lead author, Saeed Fakhran, M.D., assistant professor of ... of Pittsburgh School of Medicine. "Additional research may help ...
Breaking Medicine News(10 mins):Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:Revolutionary Treatment for Stroke Now Available in Western Australia 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3
(Date:6/17/2013)... 2013 Breezy , a portfolio ... product this week using a platform technology enabling innovative treatment ... (bad breath) is being sold in major Israeli pharmacy chains ... launch in Israel follows similar successful ... Spain earlier this year, with a repeat ...
(Date:6/17/2013)... NEW BRUNSWICK, N.J. , June 17, 2013 ... JNJ ) announced today a definitive agreement to ... and development company focused on drugs to treat ... Aragon,s androgen receptor antagonist program.  Aragon,s lead product ... inhibitor, ARN-509, in Phase 2 development for castration ...
(Date:6/17/2013)... 2013  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... acquisition of intellectual property (IP) rights related to ... of Ohio -based Buderer Drug ... commercial development of these proprietary innovations and also ... on additional Buderer Drug Company intellectual property and ...
Breaking Medicine Technology:A Big "LIKE" for Oral Hygiene 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 2Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 3Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 4Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company 5
Cached News: